The Patent Finder

Tiumbio Co., Ltd.

Also on record
Records under this name other than the patents Tiumbio Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 4 of 4 · Back to Tiumbio Co., Ltd.

PatentTitleStatus Expires Confidence
US 9,643,946Tricyclic compound and use thereof
Lapsed on the fee record
Ended May 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 9, 2025From the USPTO record
US 9,644,197Fusion protein having factor VII activity
Lapsed on the fee record
Ended May 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 9, 2025From the USPTO record
US 8,410,1462-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
Term ended
Term ended Nov 8, 2024 · From the USPTO record
Term endedTerm ended Nov 8, 2024From the USPTO record
US 9,034,850Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same
Lapsed on the fee record
Ended May 19, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 19, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited